Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia With Daridorexant in Canada

NCT06311864 is registered in ClinicalTrials.gov with PeriPharm as lead sponsor.

NCT NCT06311864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06311864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia With Daridorexant in Canada
Lead sponsor
PeriPharm
Phase
Observational
Overall status
Completed
Start date
June 20, 2024
Completion date
May 19, 2026
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia